Ophthalmology Times: June 2024

Technology offers increased usability, safety, and accuracy in MIGS procedures.

IKA Keratoconus Symposium and Controversies in Modern Eye Care shone brightly in May

Comanagement is a key component for treatment of disease.

The SimVis Gekko eye dominance strength test may change the standard of care.

Durga Borkar, MD, MMCi, recently discussed the quality data (Qdata, Verana Health) gathered on geographic atrophy as well as the GATHER 1 and GATHER 2 data.

From amniotic membrane grafting to neurotization.

Plasma emission for blepharitis, meibomian gland dysfunction, and dry eye disease.

Presenters from around the world converge on the Pacific Northwest to highlight innovation.

Durable treatments impact the quality of life of patients with retinal diseases.

Physicians wonder whether normal examination results are actually normal.

Enhanced monofocal technology may benefit patients with cataracts and dry eye.

Phase 1 multicenter study demonstrates early signs of efficacy.

Optimizing corneal neurotization outcomes with cryopreserved amniotic membrane.

Investigators looked to see if a large language model could provide safe, accurate, and readable information to patient inquiries about cataract surgery.

Three approaches to examination provide a comprehensive overview

Shift in the understanding of TED has led to a reevaluation of the Rundle curve